Article
Full-length soluble urokinase plasminogen activator receptor down-modulates nephrin expression in podocytes.
Scientific reports - 18 Sept 2015
Alfano Massimo, Cinque Paola, Giusti Guido, Proietti Silvia, Nebuloni Manuela, Danese Silvio, D'Alessio Silvia, Genua Marco, Portale Federica, Lo Porto Manuela, Singhal Pravin C, Rastaldi Maria Pia, Saleem Moin A, Mavilio Domenico, Mikulak Joanna
Abstract excerpt
Increased plasma level of soluble urokinase-type plasminogen activator receptor (suPAR) was associated recently with focal segmental glomerulosclerosis (FSGS). In addition, different clinical studies observed increased concentration of suPAR in various glomerular diseases and in other human pathologies with nephrotic syndromes such as HIV and Hantavirus infection, diabetes and cardiovascular disorders. Here, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
